Papillary (TPC-1, BCPAP) and follicular thyroid cancer cell lines (FTC-133, FTC-238,and WRO) with telomerase reverse transcriptase (TERT) mutation. This evidence concerns the gene TERT and thyroid gland follicular carcinoma.